Timing of Invasive Intracranial Pressure Monitoring Between Neurosurgeons and Intensive Care Physicians
Launched by UNIVERSITÀ DEGLI STUDI DI BRESCIA · Sep 6, 2021
Trial Information
Current as of June 06, 2025
Unknown status
Keywords
ClinConnect Summary
This perspective, multicentric and observational study will enroll patients at risk for developing intracranial hypertension, for whom it is thought invasive ICP monitoring is crucial for achieving the most appropriate treatment.
Indication to invasive ICP monitoring and its modalities will be set through a joint decision between neurosurgeons and intensive care physician, which will be led by clinical and instrumental data.
This study will be carried out in Intensive Care Unit and in Neurosurgery department.
Sample size assessment:
Sample size assessment has been performed by Monte Car...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients with acute cerebral pathology with urgent indication to invasive intracranial pressure monitoring (intraparenchymal and intraventricular)
- • Age greater than or equal to 18 years
- Exclusion Criteria:
- • Patients in whom indication to intraventricular catheter placement is stated for reasons other than the need of ICP monitoring (e.g. CSF drainage)
- • Patients in whom indication to invasive intracranial pressure monitoring is not an urgent request
- • Patients in whom a significative coagulation disorder is a contraindication for procedure
About Università Degli Studi Di Brescia
Università degli Studi di Brescia is a prestigious academic institution in Italy, dedicated to advancing medical research and education. With a strong emphasis on innovation and interdisciplinary collaboration, the university actively engages in clinical trials aimed at improving patient care and outcomes. Leveraging its extensive network of healthcare professionals and state-of-the-art facilities, the university fosters an environment conducive to groundbreaking research and the development of new therapeutic strategies. Through its commitment to scientific excellence and ethical standards, Università degli Studi di Brescia contributes significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cesena, Forlì Cesena, Italy
Legnano, Milano, Italy
Bergamo, , Italy
Brescia, , Italy
Brescia, , Italy
Caserta, , Italy
Como, , Italy
Genova, , Italy
Latina, , Italy
Lecco, , Italy
Modena, , Italy
Napoli, , Italy
Padova, , Italy
Pavia, , Italy
Roma, , Italy
Torino, , Italy
Udine, , Italy
Verona, , Italy
Patients applied
Trial Officials
Frank Rasulo
Principal Investigator
Università degli Studi di Brescia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials